oxcarbazepine has been researched along with Dizziness in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, R; Li, Y; Ou, S; Pan, S; Wang, Y; Xia, L; Zhou, Q | 1 |
| Berghuis, B; de Haan, GJ; Hulst, J; Koeleman, BPC; Lindhout, D; McCormack, M; Sander, JW; Sonsma, A | 1 |
| Chu, K; Jang, IJ; Jang, Y; Kim, TJ; Lee, S; Lee, SK; Yoon, S; Yu, KS | 1 |
| Androsova, G; Auce, P; Avbersek, A; Becker, F; Berghuis, B; Borghei, M; Campbell, E; Cavalleri, GL; Coppola, A; Craig, J; Delanty, N; Depondt, C; Francis, B; Koeleman, BPC; Krause, R; Kunz, WS; Lerche, H; Marson, AG; Sander, JW; Sills, GJ; Sisodiya, SM; Striano, P; Wassenaar, M; Wolking, S; Zara, F | 1 |
| Fadda, V; Giovannelli, F; Maratea, D; Verrotti, A; Zaccara, G | 1 |
| Besi, E; Boniface, DR; Cregg, R; Zakrzewska, JM | 1 |
| Beydoun, A; Hopwood, M; Shaibani, A; Wan, Y | 1 |
| Berenson, F; D'Souza, J; McCague, K; Saper, J; Silberstein, S; Somogyi, M | 1 |
| Berv, D; D'Souza, J; Emslie, GJ; Findling, RL; Kowatch, RA; Lehman, RB; Linden, D; McCague, K; Wagner, KD; Wamil, A; Wilens, TE | 1 |
1 review(s) available for oxcarbazepine and Dizziness
| Article | Year |
|---|---|
Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
Topics: Acetamides; Anticonvulsants; Ataxia; Carbamazepine; Dibenzazepines; Diplopia; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lacosamide; Nervous System Diseases; Oxcarbazepine; Randomized Controlled Trials as Topic; Risk Assessment; Sodium Channel Blockers; Treatment Outcome | 2013 |
3 trial(s) available for oxcarbazepine and Dizziness
| Article | Year |
|---|---|
Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study.
Topics: Adult; Aged; Analgesics; Anticonvulsants; Carbamazepine; Diabetic Neuropathies; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Oxcarbazepine; Pain; Pain Measurement; Patient Compliance; Placebo Effect; Treatment Outcome | 2006 |
Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Oxcarbazepine; Placebos; Treatment Outcome | 2008 |
A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.
Topics: Adolescent; Age Factors; Ambulatory Care; Anticonvulsants; Bipolar Disorder; Carbamazepine; Child; Diplopia; Dizziness; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Male; Nausea; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Sleep Wake Disorders; Treatment Outcome | 2006 |
5 other study(ies) available for oxcarbazepine and Dizziness
| Article | Year |
|---|---|
Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Child, Preschool; Cohort Studies; Dizziness; Drug Administration Schedule; Epilepsies, Partial; Exanthema; Female; Humans; Infant; Lamotrigine; Levetiracetam; Male; Middle Aged; Oxcarbazepine; Time Factors; Treatment Outcome; Young Adult | 2020 |
Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Dizziness; Epilepsy; Fatigue; Female; Humans; Hyponatremia; Male; Middle Aged; Oxcarbazepine; Retrospective Studies; Sodium | 2021 |
Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Diplopia; Dizziness; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Headache; Humans; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Oxcarbazepine; Seoul; Young Adult | 2021 |
Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.
Topics: Adolescent; Adult; Aged; Amines; Anticonvulsants; Ataxia; Benzodiazepines; Carbamazepine; Clobazam; Cyclohexanecarboxylic Acids; Databases, Factual; Diplopia; Dizziness; Epilepsy, Temporal Lobe; Female; Fructose; Gabapentin; gamma-Aminobutyric Acid; Hippocampus; Humans; Lamotrigine; Lethargy; Male; Middle Aged; Oxcarbazepine; Pregabalin; Retrospective Studies; Sclerosis; Topiramate; Treatment Outcome; Triazines; Valproic Acid; Vertigo; Vigabatrin; Vision Disorders; Young Adult | 2017 |
Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP).
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticonvulsants; Carbamazepine; Cluster Headache; Dizziness; England; Female; Headache; Humans; Male; Memory Disorders; Middle Aged; Neuralgia; Oxcarbazepine; Prospective Studies; Treatment Outcome; Trigeminal Neuralgia | 2015 |